Double Trouble: Pulmonary Nontuberculous Mycobacteria (Mycobacterium fortuitum) Unveiled in a Successfully Treated Tuberculosis Survivor: A Case Report
Anand R, Raghul Raj S, Thoupikka M, Maria L Rashmi, Ananthi M, Sneha Joshi
Citation Information :
R A, S RR, M T, Rashmi ML, M A, Joshi S. Double Trouble: Pulmonary Nontuberculous Mycobacteria (Mycobacterium fortuitum) Unveiled in a Successfully Treated Tuberculosis Survivor: A Case Report. Indian J Respir Care 2024; 13 (3):200-201.
We present a unique case of pulmonary nontuberculous mycobacteria (NTM) infection caused by Mycobacterium fortuitum in a patient who had previously undergone successful treatment for tuberculosis (TB). Despite the eradication of Mycobacterium tuberculosis, the patient developed respiratory symptoms and imaging findings indicative of NTM infection. This case report highlights the importance of considering NTM as a potential pathogen in immunocompetent post-TB individuals, emphasizing vigilance in diagnosis and management.
Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175(4):367–416. DOI: 10.1164/rccm.200604-571ST
Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur Respir J 2020;56(1):2000535. DOI: 10.1183/13993003.00535-2020
van Ingen J. Diagnosis of nontuberculous mycobacterial infections. Semin Respir Crit Care Med 2018;39(3):278–288. DOI: 10.1055/s-0033-1333569
Ryu WK, Lee J, Park Y, et al. Incidence and associated risk factors of nontuberculous mycobacterial infection in patients with depression. PLoS One 2023;18(8):e0290271. DOI: 10.1371/journal.pone.0290271
Chan ED, Cota-Gomez A, Podell B. Adding another piece to the puzzle of why NTM infections are relatively uncommon despite their ubiquitous nature. mBio 2021;12(2):e03577-20. DOI: 10.1128/mBio.03577-20
Ratnatunga CN, Lutzky VP, Kupz A, et al. The rise of non-tuberculosis mycobacterial lung disease. Front Immunol 2020;11:303. DOI: 10.3389/fimmu.2020.00303